Related Experiment Videos
Can we use Nature's Structure-Activity-Relationships to Make Better Drugs?
1Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC 27713, United States.
Drug Discovery Today
|August 17, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Kinetic Benefit(s) of Allosteric Receptor Blockade by Positive Allosteric Modulator Antagonists.
ACS pharmacology & translational science·2026
Receptor kinetics: Binding flux-based approaches offer complementary insight into how ligand binding evolves with time.
British journal of pharmacology·2026
Effects of diffusion, affinity, and permeation rate on drug cell therapy.
Journal of receptor and signal transduction research·2026
Therapeutic implications of target residence time.
Current opinion in structural biology·2026
Artificial intelligence agents and agentic artificial intelligence applied to precision medicine.
Drug discovery today·2026
mRNA therapeutics for restoring immune tolerance in autoimmune diseases.
Drug discovery today·2026
Sustainable drug delivery systems: Biodegradable carriers for a carbon-neutral pharma future.
Drug discovery today·2026
Facile synthesis of amorphous coordinated metal-drug frameworks for cancer immunotherapy.
Materials today. Bio·2026
Sex- and APOE-specific transcriptomic drug repurposing identifies four candidate therapeutics for Alzheimer's disease.
Alzheimer's & dementia (New York, N. Y.)·2026
AI Structural Biology in Nephrology: Powerful Scaffolds, Fragile Certainties.
Journal of the American Society of Nephrology : JASN·2026